Section Arrow
CARM.NASDAQ
- Carisma Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2025/07/18 16:33 EDT
After Hours
Last
 0.3937
+0.0015 (+0.38%)
Bid
0.3803
Ask
0.4052
High 0.3937 
Low 0.38 
Volume 905 
Regular Hours
Last
 0.3922
-0.0031 (-0.78%)
Day High 
0.4087 
Prev. Close
0.3953 
1-M High
0.56 
Volume 
459.89K 
Bid
0.3803
Ask
0.4052
Day Low
0.3801 
Open
0.4087 
1-M Low
0.369 
Market Cap 
16.52M 
Currency USD 
P/E -- 
%Yield 57.25 
10-SMA 0.41 
20-SMA 0.42 
50-SMA 0.33 
52-W High 1.27 
52-W Low 0.1417 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.22/-0.66
Enterprise Value
17.26M
Balance Sheet
Book Value Per Share
-0.88
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.63M
Operating Revenue Per Share
0.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
After Hours 2.21 -0.07 -3.07%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
After Hours 14.21 +0.135 +0.96%
NCNANuCana plc0.0477+0.0009+1.92%-- 
After Hours 0.0473 -0.0004 -0.84%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
After Hours 5.87 +0.03 +0.51%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
After Hours 5.78 -0.14 -2.36%
Quotes are at least 15-min delayed:2025/07/18 16:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.